GPA STUDIES
If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu
ABROGATE: Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non Severe, GPA
Medication involved: YES
Disease studied: GPA
Currently enrolling: YES
TAPIR: The Assessment of Prednisone in Remission Trial
Medication involved: YES
Disease studied: GPA
Currently enrolling: YES
NMB: Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis
Medication involved: NO
Disease studied: GPA, MPA, EGPA, & RP
Currently enrolling: YES (EGPA, RP)
Tissue Repository Collection Protocol
Medication involved: NO
Disease studied: GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis
Currently enrolling: YES
LoDoNaVasc: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis
Medication involved: YES
Disease studied: GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN
Currently enrolling: YES
One-Time DNA Study for Vasculitis
Medication involved: NO
Disease studied: GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN
Currently enrolling: YES
CUTIS: Clinical Transcriptomics in Systemic Vasculitis
Medication involved: NO
Disease studied: GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial
Currently enrolling: YES